REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Revolutionary CAR T-Cell Therapy Gives New Hope to Leukemia and Lymphoma Patients

CAR T-Cell Therapy
When other leukemia or lymphoma treatments have failed, CAR T-cell therapy may put the cancer into remission.

On the Cutting-edge: CAR T-Cell Therapy for Leukemia and Lymphoma

Advanced medical technology has led to the development of CAR T-cell therapy, a breakthrough treatment for ALL (acute lymphoblastic leukemia) and NHL (non-Hodgkin lymphoma). In a highly specialized laboratory procedure, the patient’s own white blood cells are modified before being returned to the body, where they find and bond with tumor cells to kill them off. Only one injection of this highly personalized treatment is necessary because the cells stay active in the body for months. This therapy for ALL and NHL is available at only a few cancer centers worldwide, including Sheba Medical Center in Israel.

CAR T-Cell Therapy
Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More